Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This dominant negative effect translates into dose-dependent altered cognitive behavior of SHANK2-R462X-expressing mice, with an impact on the penetrance of ASD.
|
21994763 |
2012 |
Intellectual Disability
|
0.390 |
GeneticVariation
|
group |
BEFREE |
Mutations in the postsynaptic scaffolding gene SHANK2 have recently been identified in individuals with autism spectrum disorder (ASD) and intellectual disability.
|
21994763 |
2012 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.
|
21994763 |
2012 |
Overgrowth
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.
|
21994763 |
2012 |
Pervasive Development Disorder
|
0.070 |
GeneticVariation
|
group |
BEFREE |
Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.
|
21994763 |
2012 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This strategy has proven largely successful in identifying ASD-susceptibility candidate loci, including gains and losses at 16p11.2, SHANK2, NRXN1, and PTCHD1.
|
22228009 |
2012 |
Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
BEFREE |
We then sequenced SHANK2 in 455 patients with ASD and 431 controls and integrated these results with those reported by Berkel et al.
|
22346768 |
2012 |
Autistic Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Here, following the discovery of two de novo SHANK2 deletions by the Autism Genome Project, we identified a novel 421 kb de novo SHANK2 deletion in a patient with autism.
|
22346768 |
2012 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.
|
22346768 |
2012 |
Overgrowth
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.
|
22346768 |
2012 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
De novo mutations revealed by whole-exome sequencing are strongly associated with autism.
|
22495306 |
2012 |
Overgrowth
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
De novo mutations revealed by whole-exome sequencing are strongly associated with autism.
|
22495306 |
2012 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Although SHANK2 and SHANK3 mutations have been implicated in ASD and intellectual disability, the involvement of SHANK1 is unknown.
|
22503632 |
2012 |
Intellectual Disability
|
0.390 |
GeneticVariation
|
group |
BEFREE |
Although SHANK2 and SHANK3 mutations have been implicated in ASD and intellectual disability, the involvement of SHANK1 is unknown.
|
22503632 |
2012 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function.
|
22699620 |
2012 |
Overgrowth
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function.
|
22699620 |
2012 |
Squamous cell carcinoma of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
Novel oncogenes identified within the 11q13 amplicon including FGF19 and SHANK2 may play important roles in ESCC tumorigenesis.
|
22761904 |
2012 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Novel oncogenes identified within the 11q13 amplicon including FGF19 and SHANK2 may play important roles in ESCC tumorigenesis.
|
22761904 |
2012 |
Polysomnography
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.
|
23251661 |
2012 |
Estradiol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.
|
23251661 |
2012 |
Estradiol level result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.
|
23251661 |
2012 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Co-occurrence of a de novo SHANK2 mutation and a CHRNA7 duplication in two reported patients with ASD and ID as well as in the patient with t(11;17;19), severe ID and behavior problems suggests convergence of these genes on a common synaptic pathway.
|
23350639 |
2013 |
Intellectual Disability
|
0.390 |
GeneticVariation
|
group |
BEFREE |
Co-occurrence of a de novo SHANK2 mutation and a CHRNA7 duplication in two reported patients with ASD and ID as well as in the patient with t(11;17;19), severe ID and behavior problems suggests convergence of these genes on a common synaptic pathway.
|
23350639 |
2013 |
Abnormal behavior
|
0.050 |
GeneticVariation
|
phenotype |
BEFREE |
Co-occurrence of a de novo SHANK2 mutation and a CHRNA7 duplication in two reported patients with ASD and ID as well as in the patient with t(11;17;19), severe ID and behavior problems suggests convergence of these genes on a common synaptic pathway.
|
23350639 |
2013 |
Language Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci.
|
23350639 |
2013 |